JAMA Medical News

Trying to Predict What the COVID-19 Pandemic Might Look Like This Winter in the US; “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge; Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People.

Related Content:

• How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave
• “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge
• Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People
• Highlights From the American Heart Association’s Scientific Sessions 2022—COVID-19’s Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More
• Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio
• After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation
• Detailed Maternal Mortality Data Suggest More Than 4 in 5 Pregnancy-Related Deaths in US Are Preventable

Medical News Associate Managing Editor Jennifer Abbasi and Conference Chair Manesh Patel, MD, discuss the latest trials and topics from the American Heart Association’s Scientific Sessions meeting. Patel is the Richard S. Stack Distinguished Professor and chief of cardiology at Duke University School of Medicine.

Related Content:

• Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021
• After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation

Conflict of Interest Disclosures:

Dr. Patel has received research grants from AstraZeneca, Bayer, Janssen, Mytonomy and Procyrion, and he currently serves on the Advisory Boards for Bayer, Janssen and Novartis.

JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Adarsh Bhimraj, MD, about new research and timely topics discussed at Infectious Disease Week (IDWeek) 2022. Dr Bhimraj, who was one of the conference chairs, is also director of Infectious Diseases Fellowship and Education at Houston Methodist Hospital.

Related Content:

• Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio

Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

Related Content:

• Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions
• Treating Cancer in Pregnant Patients After Roe v Wade Overturned
• Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

In July 2022, Nahid Bhadelia, MD, MALD, joined the White House COVID-19 Response Team as senior policy advisor for Global COVID Response. The infectious disease physician, who is on sabbatical from Boston University, spoke with JAMA Associate Managing News Editor Jennifer Abbasi about the pandemic’s true burden of disease in low- and middle-income countries and ongoing COVID-19 vaccine inequity.

Related Content:

• White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations—Undercounted Deaths, Vaccine Inequity, and More
• Global COVID-19 Update (video)

New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings; Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices.

Related Content:

• New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings
• Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices
• Reports of Asymptomatic Monkeypox Suggest That, at the Very Least, Some Infections Go Unnoticed
• After the Genome—A Brief History of Proteomics
• Dr Fauci and the Art of Science Communication
• The Dreaded “Twindemic” of Influenza and COVID-19 Has Not Yet Materialized—Might This Be the Year?

The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive

Related Content:

• The US Now Has a Research Plan for Long COVID—Is It Enough?
• Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
• Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive
• Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise
• Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change
• Addressing the Long-term Effects of COVID-19
• Long COVID: The US Federal Response (audio)
• Long COVID: The US Federal Response (video)

How Abortion Bans Could Affect Care for Miscarriage and Infertility; COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies; Code Blue—What to Do When the Shooting Starts.

Related Content:

• COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies
• How Abortion Bans Could Affect Care for Miscarriage and Infertility
• Code Blue—What to Do When the Shooting Starts

Studies dating back to the late 1950s have shown that people with South Asian ancestry have higher cardiovascular disease risk compared with other racial and ethnic groups, and the heightened risks have been observed in the US over the past 2 decades. To better understand why, in 2010 two Indian American internists, Alka Kanaya, MD, and Namratha Kandula, MD, MPH, launched the Mediators of Atherosclerosis in South Asians Living in America, or MASALA, prospective cohort study. Drs Kanaya and Kandula spoke with JAMA Medical News Associate Managing Editor Jennifer Abbasi about cardiovascular disease and risk factors among people of South Asian descent.

Related Content:

MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.

Related Content:

• The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video)
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)